title: Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
abstract: Pancreatic cancer is a highly malignant disease with a poor prognosis and it is essential to diagnose and treat the disease at an early stage. The aim of this study was to understand the underlying biochemical mechanisms of pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC) and to identify potential serum biomarkers for early detection of pancreatic cancer. 7,12-Dimethylbenz(a)anthracene (DMBA)-induced PanIN and PDAC rat models were established and the serum samples were collected. The serum samples were measured using (1)H nuclear magnetic resonance (NMR) spectroscopy and analyzed by chemometric methods including principal component analysis (PCA) and (orthogonal) partial least squares discriminant analysis ((O)PLS-DA). The related biochemical pathways were derived from KEGG analysis of the significantly different metabolites. As results, some serum metabolites demonstrated alarming metabolic changes in the precursor lesion of pancreatic cancer (PanIN-2 in this study). These changes involved elevated levels of ketone compounds including 3-hydroxybutyrate, acetoacetate, and acetone, some amino acids including asparagine, glutamate, threonine, and phenylalanine, glycoproteins and lipoproteins including N-acetylglycoprotein, LDL and VLDL, and some metabolites that have been shown to contribute to mutagenicity and cancer promotion such as deoxyguanosine and cytidine. More metabolites were shown to be significantly different between PanIN and PDAC, suggesting that a more complex set of changes occurs from noninvasive precursor lesion to invasive cancer. The serum metabonomic changes of rats with PanIN and PDAC may extend our understanding of pancreatic molecular pathogenesis, and the metabolic variations from PanIN to PDAC will be helpful to understand evolution processes of the pancreatic disease. NMR-based metabonomic analysis of animal models will be beneficial for the human study and will be helpful for the early detection of pancreatic cancer.
authors.affiliation: General Surgery Department, Fujian Medical University Union Hospital, Fuzhou 350001, China. hhuang2@aliyun.com.
authors.forename: Xianchao
authors.initials: X
authors.lastname: Lin
authors.affiliation: Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China. jianghua.feng@xmu.edu.cn.
authors.forename: Bohan
authors.initials: B
authors.lastname: Zhan
authors.affiliation: General Surgery Department, Fujian Medical University Union Hospital, Fuzhou 350001, China. hhuang2@aliyun.com.
authors.forename: Shi
authors.initials: S
authors.lastname: Wen
authors.affiliation: Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China. jianghua.feng@xmu.edu.cn.
authors.forename: Zhishui
authors.initials: Z
authors.lastname: Li
authors.affiliation: General Surgery Department, Fujian Medical University Union Hospital, Fuzhou 350001, China. hhuang2@aliyun.com.
authors.forename: Heguang
authors.initials: H
authors.lastname: Huang
authors.affiliation: Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China. jianghua.feng@xmu.edu.cn.
authors.forename: Jianghua
authors.initials: J
authors.lastname: Feng
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor; D021441:Carcinoma, Pancreatic Ductal / Q000097:blood* / Q000175:diagnosis; D055088:Early Detection of Cancer; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D053858:Metabolic Networks and Pathways; D055442:Metabolome; D055432:Metabolomics / Q000379:methods; D009367:Neoplasm Staging; D066244:Proton Magnetic Resonance Spectroscopy; D051381:Rats
chemical_list: D014408:Biomarkers, Tumor